Effectiveness of paediatric asthma clinical pathways

A narrative systematic review

Kee Hsin Chen, Chieh-Feng Chen, Hsueh Erh Liu, Pei Chuan Tzeng, Paul P. Glasziou

研究成果: 雜誌貢獻文章

11 引文 (Scopus)

摘要

Objective: To evaluate the effectiveness of clinical pathways (CPs) for paediatric asthma on length of hospital stay, additional visits due to asthma exacerbations, hospital cost, manpower and workload required for implementing CPs. Methods: Studies were eligible if they met the following criteria: children (≤18 years) with asthma, hospital or emergency department based, and study designs were (1) randomised controlled trial, (2) controlled clinical trial or (3) controlled before and after study. Two reviewers independently screened references, extracted data and assessed the risk of bias. We resolved disagreement by discussion between authors. Due to an insufficient number of studies and the heterogeneity of interventions and outcomes, we conducted a narrative systematic review with forest plots but did not pool results. Results: About 3155 relevant articles were identified through a literature search, 628 were duplicates removed, 2037 were excluded based on review of titles and abstracts and 117 were excluded because they did not meet inclusion criteria. Seven studies involving 2600 participants met the inclusion criteria. Using asthma CPs may decrease the length of hospital stay; however, CPs did not appear to reduce additional visits due to asthma exacerbations or reduce hospital costs. No eligible studies were found that quantified the manpower and workload for implementing CPs. Conclusions: Current studies suggest CPs may reduce the length of hospital stay, but insufficient evidence is available on total costs or readmissions to justify extensive uptake of asthma CPs in paediatric inpatient care. Higher quality, large randomised controlled trials are required that measure costs and a wider range of outcomes.
原文英語
頁(從 - 到)480-492
頁數13
期刊Journal of Asthma
51
發行號5
DOIs
出版狀態已發佈 - 二月 2014

指紋

Critical Pathways
Asthma
Length of Stay
Pediatrics
Hospital Costs
Workload
Randomized Controlled Trials
Costs and Cost Analysis
Hospital Departments
Controlled Clinical Trials
Hospital Emergency Service
Inpatients

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health

引用此文

Effectiveness of paediatric asthma clinical pathways : A narrative systematic review. / Chen, Kee Hsin; Chen, Chieh-Feng; Liu, Hsueh Erh; Tzeng, Pei Chuan; Glasziou, Paul P.

於: Journal of Asthma, 卷 51, 編號 5, 02.2014, p. 480-492.

研究成果: 雜誌貢獻文章

Chen, Kee Hsin ; Chen, Chieh-Feng ; Liu, Hsueh Erh ; Tzeng, Pei Chuan ; Glasziou, Paul P. / Effectiveness of paediatric asthma clinical pathways : A narrative systematic review. 於: Journal of Asthma. 2014 ; 卷 51, 編號 5. 頁 480-492.
@article{8578b67928ca44039e8ad31d6d860bbd,
title = "Effectiveness of paediatric asthma clinical pathways: A narrative systematic review",
abstract = "Objective: To evaluate the effectiveness of clinical pathways (CPs) for paediatric asthma on length of hospital stay, additional visits due to asthma exacerbations, hospital cost, manpower and workload required for implementing CPs. Methods: Studies were eligible if they met the following criteria: children (≤18 years) with asthma, hospital or emergency department based, and study designs were (1) randomised controlled trial, (2) controlled clinical trial or (3) controlled before and after study. Two reviewers independently screened references, extracted data and assessed the risk of bias. We resolved disagreement by discussion between authors. Due to an insufficient number of studies and the heterogeneity of interventions and outcomes, we conducted a narrative systematic review with forest plots but did not pool results. Results: About 3155 relevant articles were identified through a literature search, 628 were duplicates removed, 2037 were excluded based on review of titles and abstracts and 117 were excluded because they did not meet inclusion criteria. Seven studies involving 2600 participants met the inclusion criteria. Using asthma CPs may decrease the length of hospital stay; however, CPs did not appear to reduce additional visits due to asthma exacerbations or reduce hospital costs. No eligible studies were found that quantified the manpower and workload for implementing CPs. Conclusions: Current studies suggest CPs may reduce the length of hospital stay, but insufficient evidence is available on total costs or readmissions to justify extensive uptake of asthma CPs in paediatric inpatient care. Higher quality, large randomised controlled trials are required that measure costs and a wider range of outcomes.",
keywords = "Asthma, Children, Clinical pathway, Cost, Length of stay, Systematic review",
author = "Chen, {Kee Hsin} and Chieh-Feng Chen and Liu, {Hsueh Erh} and Tzeng, {Pei Chuan} and Glasziou, {Paul P.}",
year = "2014",
month = "2",
doi = "10.3109/02770903.2014.887728",
language = "English",
volume = "51",
pages = "480--492",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Effectiveness of paediatric asthma clinical pathways

T2 - A narrative systematic review

AU - Chen, Kee Hsin

AU - Chen, Chieh-Feng

AU - Liu, Hsueh Erh

AU - Tzeng, Pei Chuan

AU - Glasziou, Paul P.

PY - 2014/2

Y1 - 2014/2

N2 - Objective: To evaluate the effectiveness of clinical pathways (CPs) for paediatric asthma on length of hospital stay, additional visits due to asthma exacerbations, hospital cost, manpower and workload required for implementing CPs. Methods: Studies were eligible if they met the following criteria: children (≤18 years) with asthma, hospital or emergency department based, and study designs were (1) randomised controlled trial, (2) controlled clinical trial or (3) controlled before and after study. Two reviewers independently screened references, extracted data and assessed the risk of bias. We resolved disagreement by discussion between authors. Due to an insufficient number of studies and the heterogeneity of interventions and outcomes, we conducted a narrative systematic review with forest plots but did not pool results. Results: About 3155 relevant articles were identified through a literature search, 628 were duplicates removed, 2037 were excluded based on review of titles and abstracts and 117 were excluded because they did not meet inclusion criteria. Seven studies involving 2600 participants met the inclusion criteria. Using asthma CPs may decrease the length of hospital stay; however, CPs did not appear to reduce additional visits due to asthma exacerbations or reduce hospital costs. No eligible studies were found that quantified the manpower and workload for implementing CPs. Conclusions: Current studies suggest CPs may reduce the length of hospital stay, but insufficient evidence is available on total costs or readmissions to justify extensive uptake of asthma CPs in paediatric inpatient care. Higher quality, large randomised controlled trials are required that measure costs and a wider range of outcomes.

AB - Objective: To evaluate the effectiveness of clinical pathways (CPs) for paediatric asthma on length of hospital stay, additional visits due to asthma exacerbations, hospital cost, manpower and workload required for implementing CPs. Methods: Studies were eligible if they met the following criteria: children (≤18 years) with asthma, hospital or emergency department based, and study designs were (1) randomised controlled trial, (2) controlled clinical trial or (3) controlled before and after study. Two reviewers independently screened references, extracted data and assessed the risk of bias. We resolved disagreement by discussion between authors. Due to an insufficient number of studies and the heterogeneity of interventions and outcomes, we conducted a narrative systematic review with forest plots but did not pool results. Results: About 3155 relevant articles were identified through a literature search, 628 were duplicates removed, 2037 were excluded based on review of titles and abstracts and 117 were excluded because they did not meet inclusion criteria. Seven studies involving 2600 participants met the inclusion criteria. Using asthma CPs may decrease the length of hospital stay; however, CPs did not appear to reduce additional visits due to asthma exacerbations or reduce hospital costs. No eligible studies were found that quantified the manpower and workload for implementing CPs. Conclusions: Current studies suggest CPs may reduce the length of hospital stay, but insufficient evidence is available on total costs or readmissions to justify extensive uptake of asthma CPs in paediatric inpatient care. Higher quality, large randomised controlled trials are required that measure costs and a wider range of outcomes.

KW - Asthma

KW - Children

KW - Clinical pathway

KW - Cost

KW - Length of stay

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84901028914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901028914&partnerID=8YFLogxK

U2 - 10.3109/02770903.2014.887728

DO - 10.3109/02770903.2014.887728

M3 - Article

VL - 51

SP - 480

EP - 492

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 5

ER -